Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study
Contributors
Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; Pless, Miklos; Blumer, Liisa; Vora, Samir; Robinson, J. O.; Bernasconi, Enos; Terziroli, Benedetta; Moirandat-Rytz, Sophie; Furrer, Hansjakob; Hirschel, Bernard; Vernazza, Pietro; Sendi, Pedram; Rickenbach, Martin; Bucher, H. C.; Battegay, Manuel; Koller, M. T.Published in
Antiviral therapy, vol. 12, no. 6, p. 931-939Publication date
2007Abstract
Keywords
- Adult
- Anti-HIV Agents/ therapeutic use
- Antineoplastic Agents/ therapeutic use
- Antineoplastic Combined Chemotherapy Protocols/administration &
- Dosage/ therapeutic use
- Antiretroviral Therapy, Highly Active
- CD4 Lymphocyte Count
- Cohort Studies
- Female
- HIV Infections/complications/ drug therapy/mortality/virology
- Hepatitis C/complications
- Humans
- Kaplan-Meiers Estimate
- Lymphoma, AIDS-Related/complications/ drug therapy/mortality
- Male
- Middle Aged
- Prognosis
- Prospective Studies
UNIGE affiliation entities
Citation (ISO format)
SIMCOCK, Mathew et al. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. In: Antiviral therapy, 2007, vol. 12, n° 6, p. 931–939.
Main files (1)
Article
Identifiers
- PID : unige:7583
- PMID : 17926647
